News

Call to extend flu jab programme

08-Nov-07

The UK flu vaccination programme should be extended to include people aged 50-65 and children aged six months to three years, the RCGP has suggested.
Influenza vaccination is currently recommended for all elderly people aged 65 and over in the UK, as well as individuals in at-risk groups such as those suffering from respiratory problems.

The call comes after research revealed that influenza vaccination uptake levels for Great Britain are lagging below the European average.

This comes at a time when the WHO has emphasised the importance of influenza vaccination, stating that ‘the risk of a new flu pandemic is on its highest level since the last pandemic in 1968’.

This latest study assessed the levels of influenza vaccination coverage in England, Scotland and Wales for consecutive flu seasons from 2001 to 2006.

Vaccination coverage for Great Britain increased by over 3 per cent over the study period to reach 25.9 per cent, but still fell short of the European average, 26.5 per cent.

sanjay.tanday@haymarket.com

Comment below and tell us what you think

Comments

Only registered users may comment. Log in now or register for a free account.

Login to comment


forgotten your password?

Healthcare Republic Forums

 

Registrar

Professional development - Membership of the RCGP

Dr Sathya Naidoo explains the criteria that are required for completing iMAP. Read more

How to apply for your certificate

Applying to the RCGP for your CCT recommendation now takes three clicks, writes Fiona Erasmus. Read more

A question of capacity

Medicolegal advisor, Dr John Holden addresses some dilemmas on consent that may be faced by GPs. Read more

Show all articles

 

Latest Clinical Articles

Stable angina pectoris

Section 1 Definition and pathophysiology Read more

Endometriosis

Contributed by Mr Michael Booker, consultant obstetrician & gynaecologist, and fertility specialist ... Read more

Primary hyperparathyroidism

Contributed by Mr David Scott-Coombes, consultant endocrine surgeon at the University Hospital of Wa... Read more

Show all clinical articles

MIMS Product News

Toviaz

New drug - Toviaz

Pfizer has launched Toviaz (fesoterodine), a once-daily treatment for the symptoms of overactive bla... Read more

New drug - Tasigna

Novartis has launched Tasigna (nilotinib), a new antineoplastic agent for Philadelphia chromosome po... Read more

Ciproxin licensed for UTI in children

The licence for Ciproxin (ciprofloxacin) has been extended to include the second- and third-line tr... Read more

Jobs

 

Job of the Week